Bayer Total Liabilities 2010-2024 | BAYRY

Bayer total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Bayer total liabilities for the quarter ending December 31, 2024 were $85.275B, a 5.28% decline year-over-year.
  • Bayer total liabilities for 2024 were $85.275B, a 5.28% decline from 2023.
  • Bayer total liabilities for 2023 were $90.027B, a 0.59% decline from 2022.
  • Bayer total liabilities for 2022 were $90.558B, a 12.09% decline from 2021.
Bayer Annual Total Liabilities
(Millions of US $)
2024 $85,275
2023 $90,027
2022 $90,558
2021 $103,016
2020 $98,634
2019 $88,190
2018 $94,642
2017 $43,207
2016 $55,707
2015 $53,823
2014 $66,486
2013 $40,530
2012 $42,142
2011 $46,650
2010 $43,303
2009 $44,754
Bayer Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $85,275
2024-09-30 $83,847
2024-06-30 $90,473
2024-03-31 $91,328
2023-12-31 $90,027
2023-09-30 $91,094
2023-06-30 $92,186
2023-03-31 $90,203
2022-12-31 $90,558
2022-09-30 $90,188
2022-06-30 $96,406
2022-03-31 $98,950
2021-12-31 $103,016
2021-09-30 $100,558
2021-06-30 $101,030
2021-03-31 $101,276
2020-12-31 $98,634
2020-09-30 $102,922
2020-06-30 $96,678
2020-03-31 $84,608
2019-12-31 $88,190
2019-09-30 $94,093
2019-06-30 $93,784
2019-03-31 $93,274
2018-12-31 $94,642
2018-09-30 $91,896
2018-06-30 $106,512
2018-03-31 $45,493
2017-12-31 $43,207
2017-09-30 $60,817
2017-06-30 $51,868
2017-03-31 $55,263
2016-12-31 $55,707
2016-09-30 $57,749
2016-06-30 $58,106
2016-03-31 $57,208
2015-12-31 $53,823
2015-09-30 $57,733
2015-06-30 $58,847
2015-03-31 $61,827
2014-12-31 $66,486
2014-09-30 $53,505
2014-06-30 $48,559
2014-03-31 $48,465
2013-12-31 $40,530
2013-09-30 $42,059
2013-06-30 $43,970
2013-03-31 $43,709
2012-12-31 $42,142
2012-09-30 $42,725
2012-06-30 $43,416
2012-03-31 $44,903
2011-12-31 $46,650
2011-09-30 $46,602
2011-06-30 $46,239
2011-03-31 $43,980
2010-12-31 $43,303
2010-09-30 $43,583
2010-06-30 $45,522
2010-03-31 $46,907
2009-12-31 $44,754
2009-09-30 $47,837
2009-06-30 $45,201
2009-03-31 $49,700
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $23.657B $50.438B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $796.425B 64.61
Johnson & Johnson (JNJ) United States $379.479B 15.67
AbbVie (ABBV) United States $306.016B 17.09
Novo Nordisk (NVO) Denmark $260.636B 17.65
Roche Holding AG (RHHBY) Switzerland $248.102B 0.00
Novartis AG (NVS) Switzerland $234.183B 14.19
Merck (MRK) United States $196.697B 10.21
Sanofi (SNY) France $128.587B 12.24
Pfizer (PFE) United States $125.566B 7.12
Innoviva (INVA) United States $1.145B 10.56